Product image of Lyfnua (Gefapixant) supplied by GNH India

Lyfnua

Active Ingredient:
Gefapixant
Origin:
EU

Lyfnua (Gefapixant)

Gefapixant, the active ingredient in Lyfnua, is a P2X3 receptor antagonist presented as a 45 mg film-coated tablet for oral use. It is indicated for the treatment of chronic refractory or unexplained chronic cough in adults.

GNH India supplies Lyfnua as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide.

Manufacturer / TM Owner

Merck Sharp & Dohme B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lyfnua is used in the management of chronic cough conditions. It is specifically indicated for:

  • Chronic refractory cough: Reduces coughing in patients who do not respond to standard treatments.
  • Unexplained chronic cough: Alleviates persistent coughing when the underlying cause is unknown.
  • Chronic cough in adults: Provides relief for adults suffering from long-term coughing issues.

How It Works

  • Lyfnua works by selectively antagonizing P2X3 receptors in sensory neurons. These receptors are involved in the cough reflex pathway. By blocking the binding of ATP to P2X3 receptors, gefapixant reduces the sensitivity of the cough reflex, thereby decreasing the frequency and intensity of coughing.

Side Effects

Lyfnua may cause several side effects, which can be categorized as follows:

Common Side Effects

  • Diarrhea: Frequent bowel movements or loose stools.
  • Dyspepsia: Indigestion or discomfort in the upper abdomen.
  • Nausea: Feeling of sickness or the urge to vomit.
  • Dry mouth: Reduced saliva production in the mouth.
  • Increased salivation: Excessive production of saliva.
  • Upper abdominal pain: Discomfort or pain in the upper stomach area.
  • Upper respiratory infection: Symptoms such as a runny nose, sore throat, or cough.
  • Cough: Persistent or worsening cough.
  • Oral hypoesthesia: Reduced sensation in the mouth.
  • Oral paresthesia: Tingling or numbness in the mouth.
  • Ageusia: Loss of taste.
  • Dysgeusia: Altered or distorted taste perception.
  • Hypogeusia: Reduced taste sensitivity.
  • Headache: Pain or discomfort in the head.
  • Dizziness: Feeling lightheaded or unsteady.
  • Bladder stones: Formation of stones in the bladder.
  • Kidney stones: Formation of stones in the kidneys.
  • Urinary tract stones: Formation of stones in the urinary tract.
  • Insomnia: Difficulty falling or staying asleep.
  • Reduced appetite: Decreased desire to eat.

Serious or Rare Side Effects

  • Severe allergic reactions: Symptoms such as rash, itching, swelling, severe dizziness, or trouble breathing.

Precautions & Warnings

Lyfnua should be used with caution and certain precautions should be observed:

  • Allergies: Inform your healthcare provider if you have any known allergies to gefapixant or any of the excipients in Lyfnua.
  • Pregnancy: It is best to avoid using Lyfnua if you are pregnant, as its safety during pregnancy has not been established.
  • Breastfeeding: Consult your healthcare provider before using Lyfnua while breastfeeding.
  • Sleep apnea: Inform your healthcare provider if you have sleep apnea, as Lyfnua may affect your breathing.
  • Severe kidney impairment: Use Lyfnua with caution if you have severe kidney impairment and are not undergoing dialysis.
  • Storage: Store below 25°C: Keep in the original pack, protect from moisture.

Avoid Interactions

Lyfnua may interact with other medications, which can be categorized as follows:

Major Interactions (Avoid)

  • Sulfonamide allergies: Avoid Lyfnua if you are allergic to sulfonamides, as it may cause severe allergic reactions.
  • Severe kidney impairment: Avoid use in patients with severe kidney impairment who are not undergoing dialysis.

Moderate Interactions (Monitor Closely)

  • Other medications: Inform your healthcare provider about all medications you are taking to avoid potential interactions.
  • Sleep apnea: Monitor closely if you have sleep apnea, as Lyfnua may affect your breathing.
  • Kidney stones: Monitor for symptoms of kidney stones, such as pain in the back or side, blood in the urine, or painful urination.

Frequently Asked Questions

Lyfnua is used to treat chronic refractory or unexplained chronic cough in adults. It is specifically indicated for patients who do not respond to standard treatments or when the underlying cause of the cough is unknown.

Gefapixant works by selectively antagonizing P2X3 receptors in sensory neurons. These receptors are involved in the cough reflex pathway. By blocking the binding of ATP to P2X3 receptors, gefapixant reduces the sensitivity of the cough reflex, thereby decreasing the frequency and intensity of coughing.

The usual dose of Lyfnua is one 45 mg tablet taken twice daily. However, the prescriber will determine the appropriate dosage based on the patient's condition and response to treatment.

It is best to avoid using Lyfnua if you are pregnant, as its safety during pregnancy has not been established. Consult your healthcare provider before using Lyfnua while breastfeeding.

To order Lyfnua from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets and will ask the buyer to confirm trade or institutional credentials. The team will then reply with pricing, availability, shipping, and the import paperwork.

Lyfnua is a P2X3 receptor antagonist, which is a newer class of medication specifically targeting the cough reflex pathway. It is different from traditional cough suppressants like opioids or antihistamines, which may have broader effects and different side effect profiles.

Lyfnua should be stored below 25°C, kept in the original pack, and protected from moisture. Ensure that the tablets are not crushed, chewed, or divided unless instructed by a healthcare provider.

Lyfnua is administered orally as a film-coated tablet. It should be taken with or without food, and the tablet should be swallowed whole with a glass of water. Do not crush, chew, or divide the tablet unless instructed by a healthcare provider.

The most serious risks to watch for with Lyfnua include severe allergic reactions, such as rash, itching, swelling, severe dizziness, or trouble breathing. If you experience any of these symptoms, seek immediate medical attention.

Lyfnua should not be used by individuals who are allergic to gefapixant or any of the excipients in the medication. It should also be avoided by patients with severe kidney impairment who are not undergoing dialysis, and it is best to avoid use during pregnancy unless specifically advised by a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.